Press Releases

Date Title and Summary Additional Formats
Toggle Summary Medidata Selected for Inaugural Fortune Future 50 List
Named by Fortune as a top forward-looking, innovative global company NEW YORK --(BUSINESS WIRE)--Oct. 19, 2017-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it has been selected for the Fortune Future
View HTML
Toggle Summary Medidata Schedules Third Quarter Earnings Conference Call for October 26, 2017
NEW YORK --(BUSINESS WIRE)--Oct. 12, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its third quarter 2017 financial results before the open of the market on Thursday, October 26,
View HTML
Toggle Summary Neurological-Focused Pharmaceutical Company, Lundbeck, Continues Use of Medidata Clinical Cloud® with Multi-Year Partnership
Copenhagen -based Company to Leverage Medidata’s Cloud Technology to Accelerate Psychiatric and Neurological R&D NEW YORK & COPENHAGEN, Denmark --(BUSINESS WIRE)--Oct. 5, 2017-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical
View HTML
Toggle Summary Industry Leaders Gather at Medidata NEXT Global 2017 to Discuss How Technology is Transforming Clinical Research
Medidata Hosts Forum on Latest in Clinical Trial Innovation to Accelerate the Delivery of Life Changing Patient Treatments NEW YORK --(BUSINESS WIRE)--Oct. 2, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced
View HTML
Toggle Summary Medidata Opens New, Larger London EMEA Headquarters
Europe /EMEA Experiencing Rapid Growth, Expanded New Facilities to Meet Demand NEW YORK --(BUSINESS WIRE)--Sep. 27, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the official opening of its new EMEA
View HTML
Toggle Summary Medidata to Present at Citi 2017 Global Technology Conference
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Mike Capone , chief operating officer, and Rouven Bergmann , chief financial officer, will present at the Citi 2017 Global
View HTML
Toggle Summary Medidata's Julie Iskow Honored Among PharmaVOICE 100's Most Inspiring People
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that Julie Iskow , executive vice president and chief technology officer, has been recognized by PharmaVOICE magazine as one of
View HTML
Toggle Summary Fosun Pharma Selects Medidata's Unified Platform for Clinical Development in China
Leading Chinese Healthcare Group Adopts Medidata's Cloud Technology to Bring Operational Efficiencies to its R&D Programs NEW YORK & SHANGHAI --(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced
View HTML
Toggle Summary Medidata Earns Recognition as Leading Innovative Company and a Great Place to Work®
Medidata is named by Forbes as one of the world's most innovative companies and listed as a Great Place to Work by FORTUNE. Medidata is the only company in its space to appear on either list NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology
View HTML
Toggle Summary Medidata Expands Partnership with BeiGene to use Medidata's Patient Cloud ePRO Solution
Expanded Partnership Includes Medidata Patient Cloud ePRO to Seamlessly Collect Patient-Centric Data and Automate Manual Processes for Oncology Research NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical
View HTML

Investor Contact

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com